Gerald Li

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 9

Top Topics

Peritoneal Dialysis

Advanced Non Small Cell Lung Cancer

Ejection Fraction

Patient Reported

Top Venues

Journal for immunotherapy of cancer

JCO precision oncology

Clinical cancer research : an official journal of the American Association for Cancer Research

This page only lists publications with an associated author ORCID identifier.

Publications

Miles C Andrews, Gerald Li, Ryon P Graf, Virginia A Fisher, Jerry Mitchell, Ali Aboosaiedi, Harriet O'Rourke, Mark Shackleton, Mahesh Iddawela, Geoffrey R Oxnard, Richard S P Huang
Predictive Impact of Tumor Mutational Burden on Real-World Outcomes of First-Line Immune Checkpoint Inhibition in Metastatic Melanoma. JCO precision oncology 8 (2024)
Debra L Richardson, Julia Coelho França Quintanilha, Natalie Danziger, Gerald Li, Ethan S Sokol, Alexa B Schrock, Ericka M Ebot, Neeru Bhardwaj, Tanesha Norris, Anosheh Afghahi, Anthony Frachioni, Christina R Washington, Lauren Dockery, Julia A Elvin, Ryon P Graf, Kathleen M Moore
Effectiveness of PARP inhibitor maintenance therapy in ovarian cancer by BRCA1/2 and a scar-based HRD signature in real-world practice. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Richard S P Huang, David P Carbone, Gerald Li, Alexa Schrock, Ryon P Graf, Liangliang Zhang, Karthikeyan Murugesan, Jeffrey S Ross, Khaled Tolba, Jacob Sands, Geoffrey R Oxnard, David Spigel
Durable responders in advanced NSCLC with elevated TMB and treated with 1L immune checkpoint inhibitor: a real-world outcomes analysis. Journal for immunotherapy of cancer 11 (1) (2023)
Richard S P Huang, David P Carbone, Gerald Li, Alexa Schrock, Ryon P Graf, Liangliang Zhang, Karthikeyan Murugesan, Jeffrey S Ross, Khaled Tolba, Jacob Sands, Geoffrey R Oxnard, David Spigel
Durable responders in advanced NSCLC with elevated TMB and treated with 1L immune checkpoint inhibitor: a real-world outcomes analysis. Journal for immunotherapy of cancer 11 (1) (2023)
Julia C F Quintanilha, Michael H Storandt, Ryon P Graf, Gerald Li, Rachel B Keller, Douglas I Lin, Jeffery S Ross, Richard S P Huang, Alexa B Schrock, Geoffrey R Oxnard, Sakti Cjakrabarti, Amit Mahipal
Tumor Mutational Burden in Real-World Patients With Pancreatic Cancer: Genomic Alterations and Predictive Value for Immune Checkpoint Inhibitor Effectiveness. JCO precision oncology 7 (2023)
Richard S P Huang, David P Carbone, Gerald Li, Alexa Schrock, Ryon P Graf, Liangliang Zhang, Karthikeyan Murugesan, Jeffrey S Ross, Khaled Tolba, Jacob Sands, Geoffrey R Oxnard, David Spigel
Durable responders in advanced NSCLC with elevated TMB and treated with 1L immune checkpoint inhibitor: a real-world outcomes analysis. Journal for immunotherapy of cancer 11 (1) (2023)
Richard S P Huang, David P Carbone, Gerald Li, Alexa Schrock, Ryon P Graf, Liangliang Zhang, Karthikeyan Murugesan, Jeffrey S Ross, Khaled Tolba, Jacob Sands, Geoffrey R Oxnard, David Spigel
Durable responders in advanced NSCLC with elevated TMB and treated with 1L immune checkpoint inhibitor: a real-world outcomes analysis. Journal for immunotherapy of cancer 11 (1) (2023)
Richard S P Huang, David P Carbone, Gerald Li, Alexa Schrock, Ryon P Graf, Liangliang Zhang, Karthikeyan Murugesan, Jeffrey S Ross, Khaled Tolba, Jacob Sands, Geoffrey R Oxnard, David Spigel
Durable responders in advanced NSCLC with elevated TMB and treated with 1L immune checkpoint inhibitor: a real-world outcomes analysis. Journal for immunotherapy of cancer 11 (1) (2023)
Umang Swami, Ryon P Graf, Roberto H Nussenzveig, Virginia A Fisher, Hanna Tukachinsky, Alexa B Schrock, Gerald Li, Jeffery S Ross, Nicolas Sayegh, Nishita Tripathi, Vinay M Thomas, Geoffrey R Oxnard, Emmanuel S Antonarakis, Archana M Agarwal
SPOP Mutations as a Predictive Biomarker for Androgen Receptor Axis-Targeted Therapy in De Novo Metastatic Castration-Sensitive Prostate Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 28 (22) (2022)